IFP Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,135
| Closed | -$187K | – | 3521 |
|
|
2021
Q2 | $187K | Sell |
1,135
-1
| -0.1% | -$167 | ﹤0.01% | 936 |
|
|
2021
Q1 | $177K | Buy |
+1,136
| New | +$154K | ﹤0.01% | 893 |
|
|
2020
Q3 | – | Sell |
-30
| Closed | -$3.06K | – | 3077 |
|
|
2020
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 2319 |
|
|
2020
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 2425 |
|
|
2019
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 2432 |
|
|
2019
Q3 | $3K | Buy |
+30
| New | +$2.98K | ﹤0.01% | 2608 |
|
|
2019
Q1 | $1K | Sell |
9
-766
| -99% | -$80.1K | ﹤0.01% | 2298 |
|
|
2018
Q4 | $69K | Sell |
775
-170
| -18% | -$17.2K | ﹤0.01% | 1411 |
|
|
2018
Q3 | $104K | Sell |
945
-136
| -13% | -$14.2K | ﹤0.01% | 1452 |
|
|
2018
Q2 | $101K | Sell |
1,081
-70
| -6% | -$6.03K | ﹤0.01% | 1479 |
|
|
2018
Q1 | $105K | Hold |
1,151
| – | – | ﹤0.01% | 1359 |
|
|
2017
Q4 | $105K | Buy |
1,151
+1,145
| +19,083% | +$95.2K | ﹤0.01% | 1371 |
|
|
2017
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 4281 |
|
|
2017
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 4278 |
|
|
2017
Q1 | $0 | Sell |
6
-4
| -40% | -$236 | ﹤0.01% | 4203 |
|
|
2016
Q4 | $1K | Sell |
10
-250
| -96% | -$13.7K | ﹤0.01% | 3890 |
|
|
2016
Q3 | $15K | Buy |
260
+250
| +2,500% | +$12.3K | ﹤0.01% | 2609 |
|
|
2016
Q2 | $0 | Buy |
10
+1
| +11% | +$46 | ﹤0.01% | 4157 |
|
|
2016
Q1 | $1K | Sell |
9
-23
| -72% | -$972 | ﹤0.01% | 2280 |
|
|
2015
Q4 | $1K | Buy |
+32
| New | +$1.34K | ﹤0.01% | 3614 |
|
Other funds holding PRAH
IFP Advisors's PRAH Position: Q3 2021 in Review
IFP Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,135 shares — an estimated $187K sold.
IFP Advisors first reported a position in PRAH in Q4 2015 and held it in 20 quarters. The position peaked at $187K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- IFP Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- IFP Advisors sold 1,135 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $187K.
- IFP Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 20 quarters.
- IFP Advisors's PRA Health Sciences, Inc. position peaked at $187K in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on IFP Advisors's 13F filing for Q3 2021, filed 6 Oct 2021.